SCHEMBL12378698

SCHEMBL12378698

C=C(C)c1c2c(c(O)c3ncc(Cc4ccc(C)cc4)cc13)C(=O)N(C)C2

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KIT P10721 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12378358 0.91 CSNK1D (0.33)
SCHEMBL12378692 0.91 BCL2L1 (0.31) KIT
SCHEMBL12378696 0.89
SCHEMBL12378712 0.88 LIPG (0.34)
SCHEMBL12378695 0.87
SCHEMBL12378702 0.87 TACR1 (0.33)
SCHEMBL12378697 0.86 KIT (0.31) KIT
SCHEMBL12378717 0.85 PREP (0.33) KIT
SCHEMBL12378714 0.85 LIPG (0.35)
SCHEMBL12378703 0.84 LIPG (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8008287-B2 Use treating HIV and AIDS; tricyclic compounds such as those based on 5-sulfonamido-9-hydroxy-6,8-dihydrdo-7H-pyrrolo[3,4-g]quinoline-8-one GILEAD SCIENCES, INC. (US) 2011-08-30 US disclosed